Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Gebauer

Showing results (211-220 of 241) with videos related to

Pageof 25
Sort By:
JHEP Reports : Innovation in Hepatology|March 26, 2026
Deep Learning-Based Generation of Synthetic Multiphasic MRI In Hepatocellular Carcinoma and CirrhosisSara A Abosabie, Salma A S Abosabie, Weicheng Dai, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 29, 2022
Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor ModelAntonia M Berz, Jessica G Santana, Simon Iseke, et al.
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
JHEP Reports : Innovation in Hepatology|November 24, 2025
Immunologic effects of locoregional therapies for unresectable hepatocellular carcinomaRobin Schmidt, Bernhard Gebauer, Nilufar Akbari, et al.
European Radiology|October 31, 2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAROsman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology|May 23, 2025
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAROsman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology|August 20, 2022
Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter studyLukas Müller, Aline Mähringer-Kunz, Timo Alexander Auer, et al.
European Radiology|September 1, 2021
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trialOsman Öcal, Bora Peynircioglu, Christian Loewe, et al.
Scientific Reports|May 10, 2023
Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learningAhmet Said Kucukkaya, Tal Zeevi, Nathan Xianming Chai, et al.
European Radiology|January 13, 2024
Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomicsMoritz Gross, Steffen Huber, Sandeep Arora, et al.
Pageof 25

Showing results (211-220 of 241) with videos related to

Sort By:
Pageof 25
JHEP Reports : Innovation in Hepatology|March 26, 2026
Deep Learning-Based Generation of Synthetic Multiphasic MRI In Hepatocellular Carcinoma and CirrhosisSara A Abosabie, Salma A S Abosabie, Weicheng Dai, et al.
Journal of Vascular and Interventional Radiology : JVIR|March 29, 2022
Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor ModelAntonia M Berz, Jessica G Santana, Simon Iseke, et al.
European Radiology|July 26, 2022
Non-hypervascular hepatobiliary phase hypointense lesions detected in patients with hepatocellular carcinoma: a post hoc analysis of SORAMIC trial to identify risk factors for progressionOsman Öcal, Christoph J Zech, Matthias P Fabritius, et al.
JHEP Reports : Innovation in Hepatology|November 24, 2025
Immunologic effects of locoregional therapies for unresectable hepatocellular carcinomaRobin Schmidt, Bernhard Gebauer, Nilufar Akbari, et al.
European Radiology|October 31, 2025
Correction: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAROsman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology|May 23, 2025
Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAROsman Öcal, Christoph Johannes Zech, Maria Antonietta Bali, et al.
European Radiology|August 20, 2022
Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter studyLukas Müller, Aline Mähringer-Kunz, Timo Alexander Auer, et al.
European Radiology|September 1, 2021
Correlation of liver enhancement in gadoxetic acid-enhanced MRI with liver functions: a multicenter-multivendor analysis of hepatocellular carcinoma patients from SORAMIC trialOsman Öcal, Bora Peynircioglu, Christian Loewe, et al.
Scientific Reports|May 10, 2023
Predicting tumor recurrence on baseline MR imaging in patients with early-stage hepatocellular carcinoma using deep machine learningAhmet Said Kucukkaya, Tal Zeevi, Nathan Xianming Chai, et al.
European Radiology|January 13, 2024
Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomicsMoritz Gross, Steffen Huber, Sandeep Arora, et al.
Pageof 25